Overcoming Commercialization Challenges For Cell & Gene Therapies

Source: Catalent

The early promise offered by cell therapies and gene therapies is tempered by the challenges associated with developing, manufacturing, and delivering the drug product to patients.

This panel discussion highlights technical and regulatory hurdles associated with development and manufacturing steps, and strategies and solutions to facilitate development through commercialization.

Experts from contract development and manufacturing organizations, including Tom VanCott, Ph.D., Global Head of Product Development, Catalent Cell & Gene Therapy, discuss and debate the best approaches to successfully bring emerging therapies to patients.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma